BioVectra is a contract development and manufacturing organization (CDMO) that serves pharmaceutical and biotech companies with full-service cGMP outsourcing solutions for intermediates and active pharmaceutical ingredients (APIs). With over 45 years of experience, we are a reliable and innovative partner, specializing in:
Operating out of 4 cGMP facilities in Atlantic Canada, we have submitted over 10 product filings, including ANDA, DMF, VMF, and CMC selection preparations for the U.S. FDA, Health Canada, and the Product Development & Management Association (PDMA). These filings have been made for both synthetic and biologic molecules, including human injectable API and final drug product. Our APIs have been used in therapeutics used to treat cancer, kidney disease, cardiovascular disease, multiple sclerosis, and many other serious diseases.
BioVectra Inc. is a Mallinckrodt Pharmaceuticals company.